c-Myc is essential but not sufficient for c-Myb-mediated block of granulocytic differentiation

被引:9
作者
Kumar, A
Lee, CM
Reddy, EP
机构
[1] Temple Univ, Fels Inst Canc Res & Mol Biol, Sch Med, Philadelphia, PA 19140 USA
[2] Temple Univ, Sch Med, MD Ph D Program, Philadelphia, PA 19140 USA
[3] Montefiore Med Ctr, Dept Med, Bronx, NY 10467 USA
关键词
D O I
10.1074/jbc.M300080200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The c-myb proto-oncogene plays a central role in hematopoiesis and encodes a major translational product of 75 kDa. c-Myb is highly expressed in immature hematopoietic cells, and its expression is down-regulated during terminal differentiation. Deregulated expression of c-Myb has been shown to block terminal differentiation of hematopoietic cells. Here we have studied the mechanism of action and the nature of target genes through which c-Myb mediates the block in differentiation of 32Dc13 murine myeloid cells. We show that the ectopic overexpression of c-Myb in 32Dc13 cells results in the overexpression of c-Myc. However, enforced expression of c-Myc in 32Dc13 cells did not alter the normal pattern of differentiation. In addition, expression of dominant-negative mutants of c-Myc relieved c-Myb-mediated block in differentiation. These results led us to conclude that c-myc is a target gene of c-Myb and activation of the c-myc gene is a necessary event in Myb-mediated transformation. However, c-Myc expression alone is inadequate to elicit the phenotypic effects seen with Myb-mediated block in differentiation of myeloid cells, suggesting that activation of additional transcriptional targets by c-Myb plays a critical role in this process.
引用
收藏
页码:11480 / 11488
页数:9
相关论文
共 51 条
[1]   ONCOGENIC ACTIVITY OF THE C-MYC PROTEIN REQUIRES DIMERIZATION WITH MAX [J].
AMATI, B ;
BROOKS, MW ;
LEVY, N ;
LITTLEWOOD, TD ;
EVAN, GI ;
LAND, H .
CELL, 1993, 72 (02) :233-245
[2]   AN OLIGOMER COMPLEMENTARY TO C-MYB-ENCODED MESSENGER-RNA INHIBITS PROLIFERATION OF HUMAN MYELOID-LEUKEMIA CELL-LINES [J].
ANFOSSI, G ;
GEWIRTZ, AM ;
CALABRETTA, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (09) :3379-3383
[3]  
ARENDS MJ, 1990, AM J PATHOL, V136, P593
[4]  
ASKEW DS, 1991, ONCOGENE, V6, P1915
[5]   THE ORNITHINE DECARBOXYLASE GENE IS A TRANSCRIPTIONAL TARGET OF C-MYC [J].
BELLOFERNANDEZ, C ;
PACKHAM, G ;
CLEVELAND, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) :7804-7808
[6]  
BIES J, 1995, CELL GROWTH DIFFER, V6, P59
[7]   Myc is essential for transformation by TEL/platelet-derived growth factor receptor β (PDGFRβ) [J].
Bourgeade, MF ;
Défachelles, AS ;
Cayre, YE .
BLOOD, 1998, 91 (09) :3333-3339
[8]   CONSTITUTIVE EXPRESSION OF A C-MYB CDNA BLOCKS FRIEND MURINE ERYTHROLEUKEMIA CELL-DIFFERENTIATION [J].
CLARKE, MF ;
KUKOWSKALATALLO, JF ;
WESTIN, E ;
SMITH, M ;
PROCHOWNIK, EV .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (02) :884-892
[9]   MECHANISM OF C-MYC REGULATION BY C-MYB IN DIFFERENT CELL LINEAGES [J].
COGSWELL, JP ;
COGSWELL, PC ;
KUEHL, WM ;
CUDDIHY, AM ;
BENDER, TM ;
ENGELKE, U ;
MARCU, KB ;
TING, JPY .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (05) :2858-2869
[10]  
DELGADO MD, 1995, ONCOGENE, V10, P1659